Meanwhile, genetic variants in caveolin-1, potassium channel subfamily K member 3 (KCNK3) and eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4) have been implicated in the development of PAH through whole exome sequencing methods [28]. Here, EIF2AK4 is linked to pulmonary arterial hypertension.